BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xavier LL, Neves PFR, Paz LV, Neves LT, Bagatini PB, Timmers LFSM, Rasia-Filho AA, Mestriner RG, Wieck A. Does Angiotensin II Peak in Response to SARS-CoV-2? Front Immunol 2020;11:577875. [PMID: 33519802 DOI: 10.3389/fimmu.2020.577875] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ozkan S, Ipekci A. Serum Angiotensin II as a Biomarker in COVID-19. Biomarkers in Trauma, Injury and Critical Care 2022. [DOI: 10.1007/978-3-030-87302-8_69-1] [Reference Citation Analysis]
2 Madureira G, Soares R. The misunderstood link between SARS-CoV-2 and angiogenesis. A narrative review. Pulmonology 2021:S2531-0437(21)00160-4. [PMID: 34593362 DOI: 10.1016/j.pulmoe.2021.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Bristogiannis S, Swan D, Thachil J. Thromboprophylaxis in COVID-19 - Rationale and considerations. Adv Biol Regul 2021;81:100819. [PMID: 34332403 DOI: 10.1016/j.jbior.2021.100819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]